Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-943-8 | CAS number: 7779-88-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Assessment of the acute oral toxicity of zinc nitrate was studied in Wistar CRL/WI rats according to OECD guideline no 423 (Acute toxic Class Method) .The LD50 value was established to be greater than 300 mg/kg bw but less than 2000 mg/kg bw.
There are no specific data for zinc nitrate available on which to evaluate for acute inhalation and dermal toxicity. Read-across towards soluble zinc chloride and zinc sulphate, indicates that zinc nitrate is of very low acute inhalation and dermal toxicity not requiring a classification according to the EC criteria.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- December 17, 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Chemetall GmbH, lot/batch: n°14069326
- Expiration date of the lot/batch: N.I.
- Purity test date: >99.0%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: hygroscopic; keep away from sunligth, stable at room temperature
OTHER SPECIFICS:
homogeneous - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Ace Animals, Boyertown, PA
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation:
- Weight at study initiation: 206-241 g for males, 176-200 g for females
- Fasting period before study: yes: 16-20 hours prior to dosing
- Housing: in suspended wire cages
- Diet: fresh PMI Rat chow ad libitum exept for 16-20 hours prior to dosing
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): N.I, but mentioned temperature controlled
- Humidity (%): N.I.
- Air changes (per hr): N.I.
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
-
DOSAGE PREPARATION : the test article was mixed with distilled water to make a 20% solution (clear liquid) and to make dosing by gavage possible. The dose was based on the dry weigth of the test article.
- Doses:
- 300 mg/kg and 2000 mg/kg
- No. of animals per sex per dose:
- 3 males and 3 females at a dose level of 300 mg/kg
3 females at a dose level of 2000 mg/kg - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
in vivo: animals were observed 1/2, 1, 2, 3 and 4 hours postdose and once daily for 14 days for mortality, toxicity and pharmacological effects. Body weights were recorded immediately pretest, weekly, at death and at termination in the survivors
post mortem: all animals were humanely sacrificed using CO2 and were examined for gross pathology following study termination. Abnormal tissues were preserved in 10% neutral buffered formalin for possible future histological examination - Statistics:
- N.I.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 300 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: all six animals survived at 300mg/kg bw
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- < 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 2 of 3 females died at 2000 mg/kg bw; 1 animal was sacrificed due to moribund condition within 5 hours following gavage
- Mortality:
- 2 of 3 females at a dose level of 2000 mg/kg/bw
no mortality at a dose level of 300 mg/kg/bw - Clinical signs:
- other: at 300 mg/kg bw: no abnormal physical signs at 2000 mg/kg bw: abnormal physical signs of lethargy, piloerection, prostration, soiling/wetness of the anogenictal area and lacrimation
- Gross pathology:
- at 300 mg/kg bw: all necropsy results were normal
at 2000 mg/kg bw: necropsy results revealed opaqueness of the eyes, wetness/staining of the anogenital area and abnormalities of the gastrointestinal tract (pale/hardened stomach and red/yellow areas in the intestines) - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- LD50 is greater then 300mg/kg bw but less than 2000 mg/kg bw in rats and therefore considered to be in acute toxic category 4
- Executive summary:
The potential for oral toxicity was determined using the acute toxic class determination (OECD guideline no. 423).
3 healthy male and 3 healty female Sprague Dawley rats were dosed orally with zinc nitrate hexahydrate at 300 mg/kg. Since there was no oral toxicity, and addition three female Sprague Dawley rats were dosed at 2000 mg/kg.
At 300 mg/kg: all 6 animals survived the single 300 mg/kg oral dose. At 2000 mg/kg: 2 of 3 females died.
The LD50 is greater than 300 mg/kg but less than 2000 mg/kg bw in rats
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 300 mg/kg bw
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- Used in EU risk assessment report for zinc sulphate
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Type of coverage:
- semiocclusive
- Vehicle:
- not specified
- Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- Details on study design:
- observation period of 15 days
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- none
- Clinical signs:
- other: no effects
- Gross pathology:
- no effects
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LD50 dermal is >2000 mg/kg bwZinc sulphate is not harmful or toxic via the dermal route
- Executive summary:
In this study zinc sulphate heptahydrate was administered to the skin of five Wistar rats of each sex at 2000 mg/kg bw for 24 hours. Animals were observed for 15 days. Clinical signs of toxicity consisted of erythema (grade 1 and 2, of maximum grade 4), scales and/or scabs (scale 1 and 2, of maximum scale 3) in the treated skin area between observation days 2-8.
Zinc sulphate is not harmful or toxic via the dermal route.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Zinc chloride demonstrated acute toxicity via the inhalation route (LC50≤ 1,975 mg/m3). However, since the exposure of the animals to the size of the particles is not truly representative of exposure to humans under normal conditions, it is difficult to assess whether or not, zinc chloride is acutely toxic since a four hour LC50value could not be derived and a clear dose-response relationhip coud not be established. Airway irritation has been observed both in animals and in humans, zinc chloride has the potential to be a respiratory tract irritant.
Zinc sulphate is not acutely toxic via the dermal route (LD50 >2,000 mg/kg bw). Effects of inhalation exposure to zinc sulphate were limited to pulmonary effects only.
Justification for classification or non-classification
Soluble zinc nitrate is harmful following acute oral exposure (300 > LD50 < 2000 mg/kg bw) and meets the classification criteria for harmful if swallowed: Acute Tox. Cat. 4: H332.
There are no specific data for zinc nitrate available on which to evaluate for acute inhalation and dermal toxicity. Read-across towards soluble zinc chloride and zinc sulphate, indicates that zinc nitrate is of very low acute inhalation and dermal toxicity not requiring a classification according to the EC criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
